Entecavir (ETV) results in early viral load reduction in chronic hepatitis B (CHB) patients who have failed lamivudine (LVD) therapy: a randomized, placebo-controlled study in China (study ETV-056)
单位：[1]Shanghai Fing An Cent Hosp, Shanghai, Peoples R China[2]Shanghai Med Univ 2, Rui Fin Hosp, Shanghai, Peoples R China[3]Beijing Di Tan Hosp, Beijing, Peoples R China[4]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[5]Chongquing Med Univ, Hospital 2, Chongqing, Peoples R China[6]Bristol Myers Squibb Co, Shanghai, Peoples R China[7]Bristol Myers Squibb Co, Wallingford, CT USA
Yao Guangbi,Zhou X.,Xu Daozheng,et al.Entecavir (ETV) results in early viral load reduction in chronic hepatitis B (CHB) patients who have failed lamivudine (LVD) therapy: a randomized, placebo-controlled study in China (study ETV-056)[J].JOURNAL of GASTROENTEROLOGY and HEPATOLOGY.2006,21:A127-A127.
APA：
Yao, Guangbi,Zhou, X.,Xu, Daozheng,Wang, B.,Ren, Hong...&Macdonald, Laurie.(2006).Entecavir (ETV) results in early viral load reduction in chronic hepatitis B (CHB) patients who have failed lamivudine (LVD) therapy: a randomized, placebo-controlled study in China (study ETV-056).JOURNAL of GASTROENTEROLOGY and HEPATOLOGY,21,
MLA：
Yao, Guangbi,et al."Entecavir (ETV) results in early viral load reduction in chronic hepatitis B (CHB) patients who have failed lamivudine (LVD) therapy: a randomized, placebo-controlled study in China (study ETV-056)".JOURNAL of GASTROENTEROLOGY and HEPATOLOGY 21.(2006):A127-A127
